65 related articles for article (PubMed ID: 3196527)
1. Lipids in diabetic and nondiabetic hemodialysis and CAPD patients.
Avram MM; Antignani A; Goldwasser P; Lustig A; Fein PA; Mushnick R; Quinones E; Rao Y; Mittman N
ASAIO Trans; 1988; 34(3):314-6. PubMed ID: 3196527
[TBL] [Abstract][Full Text] [Related]
2. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Burrell D; Antignani A; Fein PA; Goldwasser P; Mittman N; Avram MM
ASAIO Trans; 1990; 36(3):M331-5. PubMed ID: 2123635
[TBL] [Abstract][Full Text] [Related]
4. Fall of cholesterol with time on dialysis: impact on atherogenicity.
Lapuz M; Avram MM; Lustig A; Goldwasser P; Antignani A; Fein PA; Mittman N
ASAIO Trans; 1989; 35(3):258-60. PubMed ID: 2597459
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
Babazono T; Miyamae M; Tomonaga O; Omori Y
Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
[TBL] [Abstract][Full Text] [Related]
6. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
[TBL] [Abstract][Full Text] [Related]
7. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
10. The impact of CAPD treatment on lipid metabolism and cardiovascular risk.
Tan D; Fein PA; Antignani A; Mittman N; Avram MM
Adv Perit Dial; 1990; 6():233-7. PubMed ID: 1982815
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis.
Avram MM; Fein PA; Antignani A; Mittman N; Mushnick RA; Lustig AR; Lapuz MH; Goldwasser P
Am J Med; 1989 Nov; 87(5N):55N-60N. PubMed ID: 2486549
[TBL] [Abstract][Full Text] [Related]
12. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
[TBL] [Abstract][Full Text] [Related]
13. Mortality risks of peritoneal dialysis and hemodialysis.
Collins AJ; Hao W; Xia H; Ebben JP; Everson SE; Constantini EG; Ma JZ
Am J Kidney Dis; 1999 Dec; 34(6):1065-74. PubMed ID: 10585316
[TBL] [Abstract][Full Text] [Related]
14. Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.
Sniderman A; Cianflone K; Kwiterovich PO; Hutchinson T; Barre P; Prichard S
Atherosclerosis; 1987 Jun; 65(3):257-64. PubMed ID: 3619989
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.
Navarro JF; Teruel JL; Lasunción MA; Mora-Fernandez C; Ortuño J
Clin Nephrol; 1998 May; 49(5):303-7. PubMed ID: 9617494
[TBL] [Abstract][Full Text] [Related]
16. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
Sezer S; Ozdemir N; Arat Z; Güz G; Sengül S; Akman B; Haberal A; Turan M; Haberal M
Adv Perit Dial; 2000; 16():177-81. PubMed ID: 11045288
[TBL] [Abstract][Full Text] [Related]
17. Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil.
Elisaf MS; Dardamanis MA; Papagalanis ND; Siamopoulos KC
Scand J Urol Nephrol; 1993; 27(1):101-8. PubMed ID: 8493456
[TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia.
Tschöpe W; Koch M; Thomas B; Ritz E
Nephron; 1993; 64(3):354-8. PubMed ID: 8341379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
